Skip to content
Screener

Kiniksa Pharmaceuticals International, plc KNSA Q4 2025 Annual earnings

Reported February 24, 2026 · Before market open

Revenue$202.1MBeat by $1.3M
EPS$0.17Miss by $0.12
Revenue estimate$200.8M
EPS estimate$0.29

Next report

Oct 27, 2026 (in 3 months)
Revenue estimate$256.7M
EPS estimate$0.36

Financials

Q4 2025

Income statement

See full
Revenue$202.1M+65.0%
Gross profit$181.2M+73.1%
Operating income$19.8M+202%
Net income$14.2M+260%
EPS (diluted)$0.18+250%

Balance sheet

See full
Cash & equivalents$165.6M-9.8%
Total debt$9.5M-3.6%
Total equity$567.6M+29.5%
Total assets$763.6M+31.5%

Cash flow

See full
Operating cash flow$53.9M+187%
CapEx$633.0K+228%
Free cash flow$53.3M+187%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$3.13B+119%
Enterprise value$2.97B+137%
P/E53×—
P/S4.6×+1.2×

Profitability

See full
Gross margin88.5%+2.9pp
Operating margin11.4%+7.7pp
Net margin8.7%+5.7pp
FCF margin20.1%+13.6pp

Returns & leverage

See full
Return on equity11.7%+8.1pp
Debt / equity0×0.0×
Current ratio3.8×+0.5×

Segments

By segment

See full
Pharmaceutical$202.1M+65.0%

By product

See full
Collaboration-—

FAQ

When did Kiniksa Pharmaceuticals International, plc report Q4 2025 earnings?
Kiniksa Pharmaceuticals International, plc (KNSA) reported Q4 2025 earnings on February 24, 2026 before market open.
What were Kiniksa Pharmaceuticals International, plc's Q4 2025 revenue and EPS?
Kiniksa Pharmaceuticals International, plc reported revenue of $202.1M and eps of $0.17 for Q4 2025.
Did Kiniksa Pharmaceuticals International, plc beat estimates in Q4 2025?
Revenue beat the consensus estimate of $200.8M by $1.3M. EPS missed the consensus estimate of $0.29 by $0.12.
How did Kiniksa Pharmaceuticals International, plc's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 65.0% from $122.5M a year earlier.
Where can I find Kiniksa Pharmaceuticals International, plc's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001730430-26-000014) and the 10-K periodic report (0001104659-26-019168) directly on SEC EDGAR. The filing index links above go to sec.gov.